Helping Entrepreneurs Achieve Success
About the Sunshine Coast Health Industry
The Health and Wellbeing industry is the Sunshine Coast’s largest employer with approximately 1,700 healthcare businesses in operation and about 21,000 people working in the sector. This industry is also one of the largest generators of economic activity in the region and predicted to double its share of the employment market by 2033.
Health Research at the University of the Sunshine Coast
Within the broad field of human health, USC researchers work across four broad research themes:
Optimising Health and Combating Disease
Innovative Health Technologies
USC’s research has a strong focus on delivering innovative, effective health solutions and improved health outcomes in regional and outer metropolitan communities. USC's researchers are embedded with industry partners in the areas of drug discovery, medical device development and implementation, health services re-design and health professional workforce development.
Are you a MedTech, Health or Wellbeing entrepreneur with plans to scale your business? Do you need guidance and practical support to turn your vision into a commercial reality?
Australian Health Accelerator (AHx) Program
AHx program is a catalyst for validating and commercialising new, innovative health related products and services with access to state-of-the-art facilities, simulation suites and laboratories.
Whether you have a great idea that needs to get off the ground or you’re already trading and looking to scale up, this program steers your venture in the right direction with tried and tested industry specific tools, resources and international connections. The AHx program is the region’s first health and wellbeing accelerator. The Innovation Centre will find, fund and accelerate 10 ambitious businesses in the region, giving them the skills, connections and opportunities they need to take their business to the next level.
This project is supported by the Australian Government Department of Industry, Innovation and Science through Incubator Support initiative funding as part of the Entrepreneurs’ Programme.
When and Where
WHEN: October 2019
WHERE: Sunshine Coast Health Institute
FACILITATOR: Innovation Centre Sunshine Coast
WHY THE SUNSHINE COAST:
Australia is home to some of the most exciting health related research and clinical innovations in the world and represents tremendous growth potential for local business. With our IC capability, $5Billion Sunshine Coast Health Precinct and other competitive advantages – the Sunshine Coast is the ideal location for AH-x.
Support from our partners
Healthtech Innovation QLD
“We are pleased to partner with the Sunshine Innovation Centre to support Queensland’s first health and wellbeing accelerator. There is a need for specialized scaling and commercialization of innovative health and medical technologies in the region to address challenges such as our aging population and increasing chronic disease rates. The AHx program will enable local health and welling start-ups to accelerate and boost their potential to improve health outcomes and transform healthcare in the region and beyond.” Tamara Mills, Director
Sunshine Coast Health Institute
“The AHx program will help drive a culture of innovation at the SCHI, whilst also providing capacity building for health-related entrepreneurs to validate and commercialise new, innovative products in one of the newest and most advanced hospitals in the world.” Anton Sanker, Director.
What you will achieve
Register for Demo Day 2020
The IC is investigating opportunities to deliver the AH-x in Brisbane and Moreton Bay with its partners from April 2020. If you are interested in learning more, please watch this space for more information in January 2020.
Frequently Asked Questions
Ms. Tamara Mills is Managing Director of ImpactXHealth, an organization supporting the growth and development of the Australasian health innovation ecosystem through both accelerating company growth and facilitating strategic investments into early stage start-ups through to small cap publicly listed companies involved in the development of breakthrough medical and healthcare technologies.
Tamara has founded, funded and led a number of companies at the intersection of healthcare and the creative industries, including Glucotek, De Motu Cordis, merging design and science to disrupt current state of care, and has a track record in both successful capital raising and driving asset growth. Tamara currently sits on the Expert Investment Advisory Committee of Uniseed advising on investment decisions in the emerging health technology space and actively manages the venture capital funds for Creative Enterprise Australia.
Tamara has extensive experience in the commercialization of innovative medical technologies across the United States, Japan, Brazil, Europe and Australia, having held executive level positions within Australia and internationally at both publicly listed and private companies. Tamara has a strong track record in portfolio asset management in commercial radiopharmaceutical space having previously managed the pipeline product portfolio for Jubilant life sciences.